ZA9711732B - Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery - Google Patents
Methods and compositions for improvement bioavailability of bioactive agents for mucosal deliveryInfo
- Publication number
- ZA9711732B ZA9711732B ZA9711732A ZA9711732A ZA9711732B ZA 9711732 B ZA9711732 B ZA 9711732B ZA 9711732 A ZA9711732 A ZA 9711732A ZA 9711732 A ZA9711732 A ZA 9711732A ZA 9711732 B ZA9711732 B ZA 9711732B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- methods
- mucosal delivery
- bioactive agents
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3397696P | 1996-12-31 | 1996-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9711732B true ZA9711732B (en) | 1998-12-28 |
Family
ID=21873566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9711732A ZA9711732B (en) | 1996-12-31 | 1997-12-30 | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6517860B1 (de) |
| EP (1) | EP0949907B1 (de) |
| JP (1) | JP2001507357A (de) |
| AT (1) | ATE234607T1 (de) |
| AU (1) | AU732347B2 (de) |
| CA (1) | CA2275502A1 (de) |
| DE (1) | DE69720045T2 (de) |
| DK (1) | DK0949907T3 (de) |
| ES (1) | ES2192705T3 (de) |
| PT (1) | PT949907E (de) |
| WO (1) | WO1998029097A1 (de) |
| ZA (1) | ZA9711732B (de) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| EP1952802A3 (de) | 1997-10-01 | 2009-06-17 | Novadel Pharma Inc. | Oraler, polarer und nicht-polarer Spray bzw. Kapsel |
| US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
| US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
| US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| ES2251985T3 (es) * | 1999-03-24 | 2006-05-16 | R.P. Scherer Technologies, Inc. | Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion. |
| GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
| DE60142043D1 (de) | 2000-04-03 | 2010-06-17 | Battelle Memorial Inst Columbu | Ausgabevorrichtungen und flüssigformulierungen |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| GB0011807D0 (en) * | 2000-05-16 | 2000-07-05 | Quadrant Holdings Cambridge | Formulation for inhalation |
| GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| GB0024271D0 (en) * | 2000-09-25 | 2000-11-15 | Colaco Camilo | Improved methods and compositions for pulmonary delivery of actives |
| JP2004526674A (ja) | 2000-12-01 | 2004-09-02 | バテル・メモリアル・インスティテュート | 液体処方物中における生体分子の安定化のための方法 |
| GB0124710D0 (en) * | 2001-10-15 | 2001-12-05 | Quadrant Healthcare Uk Ltd | Therapeutic composition |
| PT1458360E (pt) | 2001-12-19 | 2011-07-13 | Novartis Ag | Derivados de indole como agonistas do recetor s1p1 |
| CA2470520A1 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| GB0208608D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Composition |
| GB0210771D0 (en) * | 2002-05-10 | 2002-06-19 | Univ London Pharmacy | Derivatised particulate inhalation carriers |
| EP1713514B1 (de) | 2004-01-28 | 2021-11-24 | Johns Hopkins University | Arzneimittel und genträgerteilchen, die sich schnell durch schleimhautbarrieren bewegen |
| KR20050104152A (ko) | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
| JP2008507585A (ja) * | 2004-07-26 | 2008-03-13 | コセリックス インク | 微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療 |
| US7175858B2 (en) * | 2004-07-26 | 2007-02-13 | Skeletal Kinetics Llc | Calcium phosphate cements and methods for using the same |
| WO2007011396A2 (en) * | 2004-10-29 | 2007-01-25 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
| WO2006066907A1 (en) * | 2004-12-21 | 2006-06-29 | Glaxo Group Limited | Pharmaceutical formulations |
| US20070009564A1 (en) | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
| WO2007011708A2 (en) * | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| WO2007011707A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
| GB2430880A (en) * | 2005-10-04 | 2007-04-11 | Cambridge Biostability Ltd | Pharmaceutical compositions stabilized in glassy particles |
| GB0523638D0 (en) * | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
| ES2540059T3 (es) | 2006-04-26 | 2015-07-08 | Micell Technologies, Inc. | Recubrimientos que contienen múltiples fármacos |
| EP2061433B1 (de) * | 2006-09-08 | 2011-02-16 | Johns Hopkins University | Zusammensetzungen zur transportintensivierung durch die schleimhaut |
| WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
| CA2667228C (en) * | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
| CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| BRPI0810370A2 (pt) * | 2007-04-17 | 2014-10-29 | Micell Technologies Inc | Stent revestido, e, método para preparar um stent |
| AU2008256684B2 (en) * | 2007-05-25 | 2012-06-14 | Micell Technologies, Inc. | Polymer films for medical device coating |
| US20100298928A1 (en) * | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
| CN102083397B (zh) * | 2008-04-17 | 2013-12-25 | 米歇尔技术公司 | 具有生物可吸收层的支架 |
| JP2011528275A (ja) | 2008-07-17 | 2011-11-17 | ミセル テクノロジーズ，インク． | 薬物送達医療デバイス |
| US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
| US20100241220A1 (en) * | 2009-03-23 | 2010-09-23 | Mcclain James B | Peripheral Stents Having Layers |
| EP2411440B1 (de) * | 2009-03-23 | 2018-01-17 | Micell Technologies, Inc. | Verbesserte biologisch abbaubare polymere |
| CA2756386C (en) * | 2009-03-23 | 2019-01-15 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2010120552A2 (en) | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
| EP3366326A1 (de) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents mit gesteuerter elution |
| EP2453834A4 (de) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | Medizinische wirkstofffreisetzungsvorrichtung |
| EP2531140B1 (de) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit |
| US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
| EP2560576B1 (de) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents und andere vorrichtungen mit beschichtung durch eine extrazelluläre matrix |
| EP2397484A1 (de) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharidderivate und ihre Verwendung als Adjuvantien |
| WO2012009684A2 (en) | 2010-07-16 | 2012-01-19 | Micell Technologies, Inc. | Drug delivery medical device |
| US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
| WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
| CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| JP6360039B2 (ja) | 2012-05-03 | 2018-07-18 | カラ ファーマシューティカルズ インコーポレイテッド | 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法 |
| US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| ES3055223T3 (en) | 2012-05-03 | 2026-02-10 | Alcon Inc | Pharmaceutical nanoparticles showing improved mucosal transport |
| EP2956138B1 (de) | 2013-02-15 | 2022-06-22 | Kala Pharmaceuticals, Inc. | Therapeutische verbindungen und verwendungen davon |
| MX368903B (es) | 2013-02-20 | 2019-10-21 | Kala Pharmaceuticals Inc | Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas. |
| US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
| KR20150143476A (ko) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | 생흡수성 생체의학적 임플란트 |
| HK1222313A1 (zh) | 2013-05-15 | 2017-06-30 | Micell Technologies, Inc. | 可生物吸收的生物医学植入物 |
| US9458169B2 (en) | 2013-11-01 | 2016-10-04 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| MX392636B (es) | 2014-10-31 | 2025-03-24 | Glaxosmithkline Ip Dev Ltd | Formulacion en polvo. |
| AU2017324713B2 (en) | 2016-09-08 | 2020-08-13 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| US10336767B2 (en) | 2016-09-08 | 2019-07-02 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| EP3509423A4 (de) | 2016-09-08 | 2020-05-13 | Kala Pharmaceuticals, Inc. | Kristalline formen von therapeutischen verbindungen und verwendungen davon |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2037735B (en) | 1978-12-21 | 1983-11-09 | Standard Telephones Cables Ltd | Glass composition |
| JPS60258195A (ja) | 1984-06-05 | 1985-12-20 | Ss Pharmaceut Co Ltd | α．α―トレハロース脂肪酸ジエステル誘導体 |
| GB8508173D0 (en) | 1985-03-28 | 1985-05-01 | Standard Telephones Cables Ltd | Controlled delivery device |
| IE63869B1 (en) | 1986-11-06 | 1995-06-14 | Res Dev Foundation | Aerosols containing liposomes and method for their preparation |
| US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
| US5011678A (en) | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
| AU5414990A (en) | 1989-04-12 | 1990-11-05 | Aberdeen University | Slow release vitreous systems |
| US5270048A (en) | 1989-04-21 | 1993-12-14 | Borden (Uk) Limited | Controlled delivery devices |
| GB9105705D0 (en) | 1991-03-18 | 1991-05-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| GB9204466D0 (en) | 1992-03-02 | 1992-04-15 | Sandoz Ltd | Improvements in or relating to organic compounds |
| EP0679088B1 (de) * | 1992-09-29 | 2002-07-10 | Inhale Therapeutic Systems | Pulmonale abgabe von aktiven fragmenten des parathormons |
| US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
| US5591453A (en) | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
| ATE252373T1 (de) * | 1994-08-04 | 2003-11-15 | Elan Drug Delivery Ltd | Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung |
| US5747001A (en) * | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
-
1997
- 1997-12-30 ZA ZA9711732A patent/ZA9711732B/xx unknown
- 1997-12-30 US US09/000,857 patent/US6517860B1/en not_active Expired - Fee Related
- 1997-12-31 PT PT97950343T patent/PT949907E/pt unknown
- 1997-12-31 WO PCT/GB1997/003557 patent/WO1998029097A1/en not_active Ceased
- 1997-12-31 AU AU53338/98A patent/AU732347B2/en not_active Ceased
- 1997-12-31 DE DE69720045T patent/DE69720045T2/de not_active Expired - Fee Related
- 1997-12-31 DK DK97950343T patent/DK0949907T3/da active
- 1997-12-31 CA CA002275502A patent/CA2275502A1/en not_active Abandoned
- 1997-12-31 ES ES97950343T patent/ES2192705T3/es not_active Expired - Lifetime
- 1997-12-31 AT AT97950343T patent/ATE234607T1/de not_active IP Right Cessation
- 1997-12-31 EP EP97950343A patent/EP0949907B1/de not_active Expired - Lifetime
- 1997-12-31 JP JP52975098A patent/JP2001507357A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0949907A1 (de) | 1999-10-20 |
| DK0949907T3 (da) | 2003-07-14 |
| DE69720045D1 (de) | 2003-04-24 |
| PT949907E (pt) | 2003-07-31 |
| US6517860B1 (en) | 2003-02-11 |
| ATE234607T1 (de) | 2003-04-15 |
| AU732347B2 (en) | 2001-04-26 |
| JP2001507357A (ja) | 2001-06-05 |
| WO1998029097A1 (en) | 1998-07-09 |
| ES2192705T3 (es) | 2003-10-16 |
| EP0949907B1 (de) | 2003-03-19 |
| DE69720045T2 (de) | 2003-09-04 |
| CA2275502A1 (en) | 1998-07-09 |
| AU5333898A (en) | 1998-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9711732B (en) | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery | |
| EP0993831A3 (de) | Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen | |
| CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
| IL140930A0 (en) | Compounds and compositions for delivering active agents | |
| AU2190697A (en) | Buccal polar spray or capsule | |
| EP1304346A3 (de) | Konjugat aus Polyethylenglycol und Chitosan | |
| HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
| MY125651A (en) | Eplerenone compositions | |
| WO2003079972A3 (en) | Active agent delivery systems and methods for protecting and administering active agents | |
| CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
| HUP0104574A3 (en) | Analogues of glp-1, pharmaceutical compositions comprising thereof and their use | |
| CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
| PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
| MXPA01007411A (es) | Composiciones y metodos para suministro mucoso. | |
| BG105379A (en) | Pharmaceutical compositions for the treatment of acute disorders | |
| CA2238271A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
| BG103930A (en) | Eletriptan hemisulphate and caffeine containing pharmaceutical compositions | |
| CA2366679A1 (en) | Stabilized oral pharmaceutical composition containing iodide and iodate and method | |
| CA2270177A1 (en) | Transdermal administration of ment | |
| AU607496B2 (en) | Pharmaceutical compositions | |
| WO2002043706A3 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
| SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
| WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
| WO1998019697A3 (en) | Novel pharmaceutical compositions | |
| CA2287534A1 (en) | Biodegradable microparticles for the sustained delivery of therapeutic drugs |